262 related articles for article (PubMed ID: 32322338)
1. Increased Expression of
Gil-Kulik P; Świstowska M; Kondracka A; Chomik P; Krzyżanowski A; Kwaśniewska A; Rahnama M; Kocki J
Oxid Med Cell Longev; 2020; 2020():9084730. PubMed ID: 32322338
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Impact of Pregnancy-Associated Factors on the Quality of Wharton's Jelly-Derived Stem Cells Using SOX2 Gene Expression as a Marker.
Gil-Kulik P; Świstowska M; Krzyżanowski A; Petniak A; Kwaśniewska A; Płachno BJ; Galkowski D; Bogucka-Kocka A; Kocki J
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886978
[TBL] [Abstract][Full Text] [Related]
3. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
Fong CY; Subramanian A; Biswas A; Bongso A
J Cell Biochem; 2016 Apr; 117(4):815-27. PubMed ID: 26365815
[TBL] [Abstract][Full Text] [Related]
4. Potential Effect of
Świstowska M; Gil-Kulik P; Krzyżanowski A; Bielecki T; Czop M; Kwaśniewska A; Kocki J
Oxid Med Cell Longev; 2019; 2019():5084689. PubMed ID: 31281582
[TBL] [Abstract][Full Text] [Related]
5. Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.
Özmert E; Arslan U
Stem Cell Res Ther; 2020 Jan; 11(1):25. PubMed ID: 31931872
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
[TBL] [Abstract][Full Text] [Related]
7. Easy and Rapid Methods for Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Human Umbilical Wharton's Jelly-Derived Mesenchymal Stem Cells.
Abatay Sel F; Erol A; Suleymanoglu M; Kuruca DS; Savran Oguz F
Methods Mol Biol; 2024; 2736():77-84. PubMed ID: 37140810
[TBL] [Abstract][Full Text] [Related]
8. Influence of the Type of Delivery, Use of Oxytocin, and Maternal Age on
Gil-Kulik P; Chomik P; Krzyżanowski A; Radzikowska-Büchner E; Maciejewski R; Kwaśniewska A; Rahnama M; Kocki J
Oxid Med Cell Longev; 2019; 2019():1027106. PubMed ID: 31915501
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord-derived Wharton's jelly for regenerative medicine applications in orthopedic surgery: a systematic review protocol.
Main BJ; Valk JA; Maffulli N; Rodriguez HC; Gupta M; Stone IW; El-Amin SF; Gupta A
J Orthop Surg Res; 2020 Nov; 15(1):527. PubMed ID: 33176838
[TBL] [Abstract][Full Text] [Related]
10. Exosomes from acellular Wharton's jelly of the human umbilical cord promotes skin wound healing.
Bakhtyar N; Jeschke MG; Herer E; Sheikholeslam M; Amini-Nik S
Stem Cell Res Ther; 2018 Jul; 9(1):193. PubMed ID: 30005703
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells.
Thorne A; Bansal A; Necker-Brown A; Mostafa MM; Gao A; Georgescu A; Kooi C; Leigh R; Newton R
PLoS One; 2023; 18(6):e0286783. PubMed ID: 37289679
[TBL] [Abstract][Full Text] [Related]
12. Wharton's jelly-derived mesenchymal cells as a new source for the generation of microtissues for tissue engineering applications.
Durand-Herrera D; Campos F; Jaimes-Parra BD; Sánchez-López JD; Fernández-Valadés R; Alaminos M; Campos A; Carriel V
Histochem Cell Biol; 2018 Oct; 150(4):379-393. PubMed ID: 29931444
[TBL] [Abstract][Full Text] [Related]
13. Wharton's Jelly stem cells: future clinical applications.
Taghizadeh RR; Cetrulo KJ; Cetrulo CL
Placenta; 2011 Oct; 32 Suppl 4():S311-5. PubMed ID: 21733573
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Significance of the
Lee MK; Noh JK; Woo SR; Kong M; Lee YC; Lee JW; Ko SG; Eun YG
Cancer Genomics Proteomics; 2022; 19(5):591-605. PubMed ID: 35985688
[TBL] [Abstract][Full Text] [Related]
15. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro.
Gauthaman K; Yee FC; Cheyyatraivendran S; Biswas A; Choolani M; Bongso A
J Cell Biochem; 2012 Jun; 113(6):2027-39. PubMed ID: 22275115
[TBL] [Abstract][Full Text] [Related]
16. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin.
Hendijani F; Javanmard SH; Sadeghi-aliabadi H
Tissue Cell; 2015 Jun; 47(3):229-34. PubMed ID: 25779671
[TBL] [Abstract][Full Text] [Related]
17. Expression of Basement Membrane Molecules by Wharton Jelly Stem Cells (WJSC) in Full-Term Human Umbilical Cords, Cell Cultures and Microtissues.
Sánchez-Porras D; Durand-Herrera D; Carmona R; Blanco-Elices C; Garzón I; Pozzobon M; San Martín S; Alaminos M; García-García ÓD; Chato-Astrain J; Carriel V
Cells; 2023 Feb; 12(4):. PubMed ID: 36831296
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells.
Ma L; Feng XY; Cui BL; Law F; Jiang XW; Yang LY; Xie QD; Huang TH
Chin Med J (Engl); 2005 Dec; 118(23):1987-93. PubMed ID: 16336835
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.
El-Demerdash RF; Hammad LN; Kamal MM; El Mesallamy HO
Regen Med; 2015; 10(7):841-55. PubMed ID: 26541176
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.
Liu S; Hou KD; Yuan M; Peng J; Zhang L; Sui X; Zhao B; Xu W; Wang A; Lu S; Guo Q
J Biosci Bioeng; 2014 Feb; 117(2):229-235. PubMed ID: 23899897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
